For most of the last decade, the number attached to America's overdose crisis only moved in one direction. Then it turned. According to the Centers for Disease Control and Prevention, U.S. drug overdose deaths have now fallen for three consecutive years, a reversal that public-health researchers call the most encouraging shift in the epidemic's history. The progress is real, but the newest federal data also show it is uneven: some states have cut overdose deaths by a quarter or more in a single year, while a handful are moving the wrong way.
This article draws entirely on public federal data to explain how far overdose deaths have fallen, where the decline is strongest, what appears to be driving it, and how a person ready for help can find licensed treatment. You can read more about how we source our data.
105,007 → 69,973
After peaking, U.S. drug overdose deaths fell from 105,007 in 2023 to 79,384 in 2024, a 26.2% drop, the first major decline in decades. Provisional data show the fall continued into 2025, to an estimated 69,973 deaths.
Source: CDC / National Center for Health Statistics.
How big is the decline?
The clearest picture comes from the CDC's National Center for Health Statistics (NCHS), which tracks death-certificate data nationwide. Its finalized figures show overdose deaths fell from 105,007 in 2023 to 79,384 in 2024, a 26.2% decline and the first sustained drop since the modern crisis began. Provisional data released in 2026 indicate the trend held for a third year: an estimated 69,973 people died of a drug overdose in the 12-month period ending in December 2025, roughly 14% below the comparable prior period.
To put that in human terms: at the 2023 peak, the country was losing more than 105,000 people a year to overdose. Two years later that figure had fallen by tens of thousands. These are provisional counts for the most recent year and will be revised as more death certificates are processed, but the direction has been consistent across every recent release.
Opioids drove the crisis, and now the decline
Opioids, and in particular illicitly manufactured fentanyl, have been the engine of the overdose epidemic. They are now also the biggest driver of its retreat. Provisional CDC data show opioid-involved overdose deaths fell to 44,564 in 2025, down from 55,296 the year before. In the finalized 2024 data, deaths involving synthetic opioids such as illicitly made fentanyl fell even faster than the overall rate, dropping 35.6%.
Deaths involving cocaine and psychostimulants such as methamphetamine also declined, according to the CDC, though these substances did not fall as sharply as opioids and remain a serious and, in some regions, growing concern.
44,564
Opioid-involved overdose deaths fell to an estimated 44,564 in 2025, down from 55,296 in 2024. Deaths involving synthetic opioids like fentanyl fell 35.6% in the finalized 2024 data.
Source: CDC / National Center for Health Statistics.
The decline is uneven across states
National numbers hide wide regional differences. In the provisional data for the 12 months ending December 2025, several states posted declines of 25% or more, including Rhode Island, New York, North Carolina, Alabama, and Vermont. The finalized 2024 data told a similar story of concentrated progress, with declines of 35% or more in states such as Louisiana, Michigan, New Hampshire, Ohio, Virginia, West Virginia, Wisconsin, and Washington, D.C.
But not every state is improving. In the same provisional 2025 period, a small group of states saw overdose deaths rise by 10% or more, including New Mexico, Arizona, and Colorado. The pattern suggests that the drug supply, access to treatment, and the reach of harm-reduction tools still vary enormously by geography, so a national success story can coexist with local crises.
25% or more
In provisional 2025 data, states including Rhode Island, New York, North Carolina, Alabama, and Vermont cut overdose deaths 25% or more, while New Mexico, Arizona, and Colorado saw increases of 10% or more.
Source: CDC / National Center for Health Statistics (provisional, 12 months ending December 2025).
What is driving the turnaround?
No single factor explains the reversal, and researchers are careful not to overclaim. But the leading explanations point in a consistent direction. Naloxone, the opioid-overdose reversal medication, is far more widely available than it was five years ago, including over the counter. Access to treatment, and especially to medications for opioid use disorder such as buprenorphine and methadone, has expanded. Harm-reduction programs, public-health messaging, and shifts in the illicit drug supply itself are also cited as contributors.
What ties these together is a simple through-line: connecting more people to care, and keeping more people alive long enough to reach it, changes outcomes at the population level. The decline is evidence that the crisis is not immovable, and that investment in treatment and prevention shows up in the numbers.
Why treatment access still matters
A falling death rate is not the same as a solved problem. Even as overdose deaths decline, tens of millions of Americans still have a substance use disorder, and only a fraction receive treatment in any given year, a divide we explore in the addiction treatment gap. The progress in the data is, in large part, a story about access, and access is exactly where individuals, families, and communities can still make a difference. Every person who finds the right level of care is one more data point moving in the right direction.
Finding licensed treatment
If you or someone you care about is ready to look for help, free and trustworthy resources exist. The federal government operates FindTreatment.gov, a searchable directory of licensed facilities, and the SAMHSA National Helpline (1-800-662-HELP / 4357) offers free, confidential, 24/7 referrals in English and Spanish. If there is any risk of immediate harm, call or text 988 to reach the Suicide and Crisis Lifeline. Peer support matters too; our support groups directory lists national mutual-aid organizations and how to find a meeting.
Rehab Connect is a free, independent directory that mirrors the licensed facilities in SAMHSA's FindTreatment.gov data. It lets you browse programs by state and by the services you need, with no lead forms and no referral fees, so you can contact facilities directly. It exists to make the same public data easier to navigate, nothing more.
The overdose numbers are finally falling. Behind that trend are hundreds of thousands of people who found a way to stay alive and get well, and the surest way to keep the line moving down is to help the next person find care.
Sources
- CDC / National Center for Health Statistics, U.S. Overdose Deaths Decrease for Third Consecutive Year in 2025 (provisional data, May 2026). cdc.gov/nchs/pressroom/releases/20260513.html
- CDC / National Center for Health Statistics, U.S. Overdose Deaths Decrease Almost 27% in 2024 (provisional data, May 2025). cdc.gov/nchs/pressroom/releases/20250514.html
- CDC / National Center for Health Statistics, Drug Overdose Deaths in the United States, 2023–2024, NCHS Data Brief No. 549. cdc.gov/nchs/products/databriefs/db549.htm
- CDC / NCHS, Vital Statistics Rapid Release — Provisional Drug Overdose Death Counts. cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
- SAMHSA, FindTreatment.gov. findtreatment.gov
All figures come from publicly available U.S. federal data from the CDC's National Center for Health Statistics. Finalized figures are used for 2023 and 2024; 2025 figures are provisional and subject to revision, so the most recent year-over-year percentages may change. State-level highlights reflect the CDC's reported provisional comparisons (12 months ending December 2025) and the finalized 2024 data. Because deaths may involve more than one drug, category figures do not sum to the total.